NVCT
Nuvectis Pharma, Inc.
Pharmaceutical PreparationsNasdaq<br>Emerging growth company
Total Trades
86
Buys
84
Sells
1
Largest Trade
N/A
Insiders
8
Institutional Funds
39
Inst. Value
$1M+
Activist Filings
11
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| BENTSUR RON | Chairman & CEO | BUY | $15K–$50K | 5K | $5.72 | Nov 6, 2025 |
| Sanchez Juan | Director | BUY | $50K–$100K | 13K | $5.79 | Nov 6, 2025 |
| Kaplan Matthew L. | Director | BUY | $50K–$100K | 11K | $5.84 | Nov 6, 2025 |
| Mosseri Marlio Charles | 10% Owner | BUY | $500K+ | 155K | $6.18 | Oct 29, 2025 |
| Mosseri Marlio Charles | 10% Owner | BUY | $15K–$50K | 6K | $7.99 | Jun 24, 2025 |
| Mosseri Marlio Charles | 10% Owner | BUY | $100K–$500K | 33K | $8.06 | Jun 20, 2025 |
| Mosseri Marlio Charles | 10% Owner | BUY | $100K–$500K | 21K | $8.11 | May 13, 2025 |
| Mosseri Marlio Charles | 10% Owner | BUY | $100K–$500K | 27K | $8.60 | May 9, 2025 |
| BENTSUR RON | Chairman & CEO | BUY | $15K–$50K | 5K | $4.65 | Dec 26, 2024 |
| Poradosu Enrique | Chief Science & Bu… | BUY | $1K–$15K | 2K | $4.99 | Nov 20, 2024 |
| BENTSUR RON | Chairman & CEO | BUY | $50K–$100K | 20K | $4.92 | Nov 18, 2024 |
| Carson Michael J. | Vice President | SELL | $15K–$50K | 3K | $8.16 | Nov 8, 2024 |
| Carson Michael J. | Vice President | GRANT | N/A | 63K | — | Nov 8, 2024 |
| BENTSUR RON | Chairman & CEO | BUY | $1K–$15K | 640 | $11.08 | Oct 12, 2023 |
| BENTSUR RON | Chairman & CEO | BUY | $1K–$15K | 1K | $11.21 | Oct 10, 2023 |
| BENTSUR RON | Chairman & CEO | BUY | $15K–$50K | 3K | $11.01 | Oct 6, 2023 |
| BENTSUR RON | Chairman & CEO | BUY | $1K–$15K | 350 | $14.61 | Aug 16, 2023 |
| BENTSUR RON | Chairman & CEO | BUY | $1K–$15K | 300 | $14.73 | Aug 11, 2023 |
| Mosseri Marlio Charles | 10% Owner | BUY | $1K–$15K | 860 | $13.88 | Aug 1, 2023 |
| Mosseri Marlio Charles | 10% Owner | BUY | $15K–$50K | 3K | $13.91 | Jul 31, 2023 |
| Mosseri Marlio Charles | 10% Owner | BUY | $15K–$50K | 2K | $13.98 | Jul 28, 2023 |
| Mosseri Marlio Charles | 10% Owner | BUY | $100K–$500K | 10K | $13.97 | Jul 27, 2023 |
| BENTSUR RON | Chairman & CEO | BUY | $1K–$15K | 335 | $14.92 | Jul 24, 2023 |
| Mosseri Marlio Charles | 10% Owner | BUY | $100K–$500K | 8K | $14.47 | Jul 24, 2023 |
| Mosseri Marlio Charles | 10% Owner | BUY | $100K–$500K | 8K | $14.84 | Jul 20, 2023 |
| BENTSUR RON | Chairman & CEO | BUY | $1K–$15K | 200 | $14.33 | Jul 20, 2023 |
| Mosseri Marlio Charles | 10% Owner | BUY | $100K–$500K | 9K | $14.84 | Jul 19, 2023 |
| BENTSUR RON | Chairman & CEO | BUY | $1K–$15K | 260 | $15.52 | Jul 18, 2023 |
| Mosseri Marlio Charles | 10% Owner | BUY | $15K–$50K | 3K | $15.09 | Jul 13, 2023 |
| Mosseri Marlio Charles | 10% Owner | BUY | $100K–$500K | 10K | $15.36 | Jul 12, 2023 |
| Mosseri Marlio Charles | 10% Owner | BUY | $100K–$500K | 9K | $15.19 | Jul 10, 2023 |
| Mosseri Marlio Charles | 10% Owner | BUY | $15K–$50K | 3K | $15.01 | Jul 7, 2023 |
| BENTSUR RON | Chairman & CEO | BUY | $1K–$15K | 320 | $14.88 | Jul 7, 2023 |
| Mosseri Marlio Charles | 10% Owner | BUY | $15K–$50K | 1K | $15.52 | Jul 6, 2023 |
| Mosseri Marlio Charles | 10% Owner | BUY | $100K–$500K | 17K | $16.46 | Jun 27, 2023 |
| BENTSUR RON | Chairman & CEO | BUY | $1K–$15K | 750 | $16.50 | Jun 27, 2023 |
| Mosseri Marlio Charles | 10% Owner | BUY | $1M+ | 73K | $17.43 | Jun 26, 2023 |
| Mosseri Marlio Charles | 10% Owner | BUY | $100K–$500K | 13K | $17.72 | Jun 23, 2023 |
| BENTSUR RON | Chairman & CEO | BUY | $1K–$15K | 500 | $17.88 | Jun 22, 2023 |
| Mosseri Marlio Charles | 10% Owner | BUY | $100K–$500K | 13K | $17.75 | Jun 20, 2023 |
| Mosseri Marlio Charles | 10% Owner | BUY | $500K+ | 32K | $17.71 | Jun 16, 2023 |
| BENTSUR RON | Chairman & CEO | BUY | $1K–$15K | 350 | $17.45 | Jun 9, 2023 |
| BENTSUR RON | Chairman & CEO | BUY | $1K–$15K | 330 | $17.28 | Jun 1, 2023 |
| BENTSUR RON | Chairman & CEO | BUY | $1K–$15K | 200 | $17.49 | May 26, 2023 |
| BENTSUR RON | Chairman & CEO | BUY | $1K–$15K | 320 | $17.02 | May 18, 2023 |
| Poradosu Enrique | Chief Science & Bu… | BUY | $1K–$15K | 500 | $11.55 | Mar 28, 2023 |
| BENTSUR RON | Chairman & CEO | BUY | $1K–$15K | 230 | $12.13 | Mar 27, 2023 |
| BENTSUR RON | Chairman & CEO | BUY | $1K–$15K | 480 | $12.08 | Mar 23, 2023 |
| Shemesh Shay | Chief Dev. & Ops. … | BUY | $1K–$15K | 420 | $11.99 | Mar 22, 2023 |
| Shemesh Shay | Chief Dev. & Ops. … | BUY | $1K–$15K | 670 | $10.71 | Mar 17, 2023 |
🔓Seeing ranges? Sign in for exact trade values — free forever
Institutional Ownership
13F filings as of Dec 31, 2025 · 39 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| IRIDIAN ASSET MANAGEMENT LLC/CT | 536K | $1M+ | SH |
| BALDWIN WEALTH PARTNERS LLC/MA | 390K | $1M+ | SH |
| Occam Crest Management LP | 380K | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 312K | $1M+ | SH |
| STATE STREET CORP | 155K | $1M+ | SH |
| OPPENHEIMER & CO INC | 74K | $500K+ | SH |
| FORBES J M & CO LLP | 59K | $100K–$500K | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 44K | $100K–$500K | SH |
| BARCLAYS PLC | 24K | $100K–$500K | SH |
| Austin Wealth Management, LLC | 20K | $100K–$500K | SH |
| JANE STREET GROUP, LLC | 18K | $100K–$500K | SH (Call) |
| Nuveen, LLC | 17K | $100K–$500K | SH |
| GOLDMAN SACHS GROUP INC | 15K | $100K–$500K | SH |
| CIBC Private Wealth Group LLC | 15K | $100K–$500K | SH |
| Avalon Trust Co | 14K | $100K–$500K | SH |
| NATIONS FINANCIAL GROUP INC, /IA/ /ADV | 13K | $50K–$100K | SH |
| RHUMBLINE ADVISERS | 8K | $50K–$100K | SH |
| UBS Group AG | 8K | $50K–$100K | SH |
| Bank of New York Mellon Corp | 8K | $50K–$100K | SH |
| VANGUARD GROUP INC | 6K | $15K–$50K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Nov 5, 2024
1.5%
289K shares
SC 13G/A · Feb 28, 2024
15.0%
2.6M shares
SC 13G/A · Feb 1, 2024
8.7%
1.5M shares
SC 13G/A · Feb 1, 2024
8.6%
1.5M shares
SC 13G/A · Jan 31, 2024
5.2%
908K shares
SC 13G · Apr 3, 2023
6.4%
948K shares
SC 13G · Feb 13, 2023
8.2%
1.2M shares
SC 13G · Feb 13, 2023
8.3%
1.2M shares
SC 13G/A · Jan 9, 2023
16.3%
2.4M shares
SC 13G/A · Mar 28, 2022
11.0%
1.4M shares
SC 13D · Mar 28, 2022
21.5%
2.7M shares